Created in 2013 (Switzerland), LINACTRO own 2951 sister brands and 17477 competing brands. LINACTRO is a brand of NOVARTIS N, listed on the stock exchange of Zurich. The ISIN, the company's International Securities Identification Number, is CH0012005267. LINACTRO belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
NOVARTIS N
(LINACTRO)
over 5 years*
CHF 99.86